Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2...

  • Main
  • 2015 / 10
  • Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2...
Clinical Cancer Research 2015 / 10

Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas

Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., Guehennec, J., Knoff, D., Labussiere, M., Marie, Y., Ligon, A. H., Mokhtari, K., Hoang-Xuan, K., Sanson, M., Alexander,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1015
Date:
October, 2015
File:
PDF, 1.43 MB
english, 2015
Conversion to is in progress
Conversion to is failed